ebselen has been researched along with daunorubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Arafah, MM; Najjar, TA; Saad, SY | 1 |
2 other study(ies) available for ebselen and daunorubicin
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardiomyopathy in rats.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Aspartate Aminotransferases; Azoles; Cardiomyopathies; Cardiotonic Agents; Creatine Kinase, MB Form; Daunorubicin; Glutathione; Glutathione Peroxidase; Injections, Subcutaneous; Isoindoles; L-Lactate Dehydrogenase; Male; Myocardium; Nitrates; Nitrites; Organoselenium Compounds; Rats; Rats, Wistar | 2006 |